Author

Filippo Ferdinando Cosini

Observed names: Filippo Cosini, Filippo F. Cosini

Institutions: Azienda Sanitaria Locale N. 2 Savonese, Ospedale Santa Corona

Observed institutions: Ospedale Policlinico San Martino, Azienda Sanitaria Locale N. 2 Savonese, Ospedale Santa Corona, University of Genoa

ORCID: 0000-0002-7230-6186

Observed ORCID: 0000-0002-7230-6186

OpenAlex ID: A5011520957

Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity

2020 · Marco Caminati, Alessandra Vultaggio, et al. · Respiratory Medicine · 63

Quick Olfactory Sniffin’ Sticks Test (Q-Sticks) for the detection of smell disorders in COVID-19 patients

2021 · Diego Bagnasco, Giovanni Passalacqua, et al. · World Allergy Organization Journal · 21

Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association – GAA) document

2021 · Fulvio Braido, Angelica Tiotiu, et al. · Journal of Asthma · 9

Extrafine formulation of beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurized metered-dose inhaler in the treatment of asthma: a review

2025 · Erminia Ridolo, Manlio Milanese, et al. · Therapeutic Advances in Respiratory Disease · 5

Background therapy in severe asthma on monoclonal antibody treatment in real life

2025 · Filippo F. Cosini, Diego Bagnasco, et al. · Respiratory Medicine · 4

Author response for "Extrafine formulation of beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurized metered-dose inhaler in the treatment of asthma: a review"

2025 · Erminia Ridolo, Manlio Milanese, et al. · Publons reviews and discussion

Works count: 6

Citation count: 102

H-index: 4

I10-index: 2